Healthways Inc. (NASDAQ:HWAY)’s share price reached a new 52-week high during trading on Friday . The stock traded as high as $22.85 and last traded at $22.33, with a volume of 1,393,171 shares changing hands. The stock had previously closed at $22.58.

Several equities analysts recently commented on the stock. Jefferies Group reaffirmed a “hold” rating and set a $13.00 target price on shares of Healthways in a report on Tuesday, May 3rd. Zacks Investment Research raised shares of Healthways from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Barrington Research dropped their price target on shares of Healthways from $15.00 to $14.00 and set an “outperform” rating for the company in a research report on Friday, April 29th. FBR & Co reissued a “buy” rating on shares of Healthways in a research report on Friday, April 29th. Finally, Oppenheimer Holdings Inc. cut shares of Healthways from an “outperform” rating to a “market perform” rating in a research report on Friday. One analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $18.50.

The company’s market capitalization is $816.69 million. The company has a 50 day moving average of $14.08 and a 200-day moving average of $12.02.

Healthways (NASDAQ:HWAY) last released its earnings results on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.01 by $0.53. During the same period last year, the firm posted $0.11 EPS. The company earned $125 million during the quarter, compared to analysts’ expectations of $186.88 million. Healthways’s quarterly revenue was up 10.2% compared to the same quarter last year. Equities analysts predict that Healthways Inc. will post $0.43 earnings per share for the current year.

An institutional investor recently raised its position in Healthways stock. BNP Paribas Arbitrage SA increased its stake in Healthways Inc. (NASDAQ:HWAY) by 37.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 80,127 shares of the company’s stock after buying an additional 21,702 shares during the period. BNP Paribas Arbitrage SA owned about 0.22% of Healthways worth $1,031,000 as of its most recent SEC filing.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.